Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation

Liver International

Volumn 27, Issue 1, 2007, Pages 81-85

  Chan, Albert C Y ^a   Lo, Chung Mau ^a   Ng, Kelvin Kwok Chai ^a   Chan, See Ching ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Liver transplantation; Tuberculosis

Indexed keywords

AMIKACIN; ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 DERIVATIVE; ISONIAZID; LEVOFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STEROID; STREPTOMYCIN; TACROLIMUS; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COUGHING; DEATH; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SAFETY; EMPYEMA; FEVER; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TOXICITY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; ORCHIECTOMY; ORCHITIS; RECURRENT CANCER; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTIONS; TUBERCULOSIS;

EID: 33846438284     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01397.x     Document Type: Article

References (15)

1. Naqvi SA, Hussain M, Askari H, et al. Is there a place for prophylaxis against tuberculosis following renal transplantation? Transplant Proc 1992; 24: 1912.
2. Singh N, Paterson D. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implication for management. Clin Infect Dis 1998; 27: 1266-77.
3. Stoblen F, Neuhaus K, Neumann O. Tuberculosis in liver transplant recipients: Recurrence after transplantation? Transplant Proc 1994; 26: 3604-5.
4. Torre-Cisneros J, De La Mata M, Rufian S, Villanueva JL. Importance of surveillance mycobacterial cultures after liver transplantation. Transplantation 1995; 60: 1054-5.
5. Nishizaki T, Yanaga K, Soejima Y, et al. Tuberculosis following liver transplantation: Report of a case and review of the literature. Transplant Int 1996; 9: 589-92.
6. Kiuchi T, Tanaka Y, Inomoto S, et al. Experience of tacrolimus based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: Interaction with rifampicin and side effects. Tranplant Proc 1996; 28: 3171-2.
7. Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in spain. Transplantation 1997; 63: 1278-86.
8. Meyers B, Halpern M, Sheiner, et al. Tuberculosis in liver transplant patients. Transplantation 1994; 58: 301-6.
9. Cavosoglu C, Cicek-Saydam C, Karasu Z, et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients. Clin. Transplant 2002; 16: 257-61.
10. Benito N, Sued O, Moreno A, et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Tranplantation 2002; 74: 1381-6.
11. Jereb JA, Burwen DR, Dooley SW, et al. Nosocomial outbreak of tuberculosis in a renal transplant unit: Application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis 1993; 168: 1219-24.
12. Kiuchi T, Tanaka K, Inomata Y, et al. Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated by graft tuberculosis: Interaction with rifampicin and side-effects. Transplant Proc 1996; 28: 3171-2.
13. American Thoracic Society, CDC, and Infectious Diseases Society of America: Treatment of Tuberculosis. Morbid Mortal Wkly Rep 2003; 52 (RR11): 1-77.
14. Lo CM, Fan ST, Liu CL, et al. Minimum graft size for successful living donor liver transplantation. Transplantation 1999; 68: 1112-6.
15. Yang ZF, Ho DW, Chu AC, et al. Linking inflammation to acute rejection in small-for-size liver allografts: The potential role of early macrophage activation. Am J Transplant 2004; 4: 196-209.